News
-
-
-
PRESS RELEASE
Broad-Spectrum Antiviral Drug NV-387 Cleared for Phase II Clinical Trial Application by the National Ethics Committee of the Democratic Republic of Congo
NanoViricides, Inc. receives approval from CNES for Phase II clinical trial of NV-387 in DRC for MPox disease treatment. CEO highlights drug's broad-spectrum antiviral capabilities -
-
PRESS RELEASE
Burda Digital SE submits specified demand for squeeze-out and determines cash compensation for transfer of the shares of the minority shareholders of New Work SE at EUR 105.65
Burda Digital SE submits request for squeeze-out of minority shareholders of New Work SE at EUR 105.65 per share. Court-appointed expert confirms cash compensation -
PRESS RELEASE
Sto SE & Co. KGaA: consolidated turnover declines by 4.6 % to EUR 324.8 million in the first quarter of 2025
Sto SE & Co. KGaA reports a 4.6% decline in consolidated turnover to EUR 324.8 million in Q1 2025 due to adverse weather and economic conditions impacting the construction sector -
PRESS RELEASE
The Battery Show Europe 2025 Critical Agenda Highlights Moves to Global Collaboration, Regulation and Supply Chain Resilience
The Battery Show Europe 2025 keynote lineup announced featuring industry leaders from BMW, CATL, Mercedes Benz and more. Key themes include supply chain, regulations and market trends analysis -
-
-